If you cannot name it in five seconds, start there
In 2024, the FDA also approved it for reducing cardiovascular risk in adults with obesity or who are overweight
Researchers from the University of Oxford discovered that people on drugs including semaglutide, better known as Wegovy, and tirzepatide, also known as Mounjaro, lose weight during treatment but, on average, regain it within 20 months of stopping the jabs
Some protocols use BPC-157 only during the GLP-1 titration phase when GI support is most needed, then discontinue it once the maintenance dose is reached and well-tolerated
PRJNA1172178
In the Liraglutide Effect and Action in Diabetes trial (LEAD-3), GLP-1RA liraglutide treatment significantly reduced body fat, but there was no significant change in lean body mass